<PAGE> 1
<TABLE>
<CAPTION>
<S> <C>
---------------------------
UNITED STATES | OMB APPROVAL |
SECURITIES AND EXCHANGE COMMISSION |---------------------------|
Washington, D.C. 20549 | OMB Number 3235-0058 |
| Expire: May 31, 1997 |
| Estimated average burden |
FORM 12b-25 | hours per response...2.50 |
---------------------------
------------------------
| SEC FILE NUMBER |
| |
NOTIFICATION OF LATE FILING ------------------------
------------------------
(Check One): [ ]Form 10-K [ ]Form 20-F [X] Form 10-Q [ ]Form N-SAR | CUSIP NUMBER |
| |
For Period Ended: September 30, 1995 -----------------------
--------------------
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended:
--------------------------------
-------------------------------------------------------------------------------
| Read Instruction (on back page) Before Preparing form: Please Print or Type. |
| |
| Nothing in this form shall be construed to imply that the Commission has |
| verified any information contained herein. |
-------------------------------------------------------------------------------
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:
- --------------------------------------------------------------------------------
PART I - REGISTRANT INFORMATION
The Wendt - Bristol Health Services Corporation
- --------------------------------------------------------------------------------
Full Name of Registrant
- --------------------------------------------------------------------------------
Former Name if Applicable
Two Nationwide Plaza, Suite 760
- --------------------------------------------------------------------------------
Address of Principal Executive Office (Street and Number)
Columbus, Ohio 43215
- --------------------------------------------------------------------------------
City, State and Zip Code
PART II - RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)
(a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
(b) The subject annual report, semi-annual report, transition report on
Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof, will be
[X] filed on or before the fifteenth calendar day following the prescribed
due date; or the subject quarterly report of transition report on
Form 10-Q, or portion thereof will be filed on or before the fifth
calendar day following the prescribed due date; and
(c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
PART III - NARRATIVE
State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q,
N-SAR, or the transition report or portion thereof, could not be filed within
the prescribed time period.
Registrant has a limited number of accounting and financial personnel.
In recent weeks significant time has had to be devoted to non-recurring
priorities which include the re-financing of equipment and certain
mortgages.
(Attach Extra Sheets if Needed)
SEC 1344 (6/94)
</TABLE>
<PAGE> 2
<TABLE>
<CAPTION>
PART IV - OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this notification
<S> <C> <C>
Sheldon A. Gold 614 221-6000
------------------------------------------------ ---------- -----------------------------------------------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act
of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or
for such shorter period that the registrant was required to file such report(s) been filed? If
answer is no, identify report(s). [X] Yes [ ] No
---------------------------------------------------------------------------------------------------------------
(3) Is it anticipated that any significant change in results of operations from the corresponding period for
the last fiscal year will be reflected by the earnings statements to be included in the subject report or
portion thereof? [ ] Yes [X} No
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate,
state the reasons why a reasonable estimate of the results cannot be made.
- --------------------------------------------------------------------------------------------------------------------
The Wendt-Bristol Health Services Corporation
-------------------------------------------------------------------
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
Date November 14, 1995 By /s/ Sheldon A. Gold, Its President
---------------------------------------------------------- -------------------------------------------------
INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized-
representative. The name and title of the person signing the form shall be typed or printed beneath the signature.
If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer),
evidence of the representative's authority to sign on behalf of the registrant shall be filed with the form.
----------------------------------------------------- ATTENTION -----------------------------------------------------
| Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001) |
---------------------------------------------------------------------------------------------------------------------
GENERAL INSTRUCTIONS
1. This form is required by Rule 12b-25 (17 CFR 240.12b-25) of the General Rules and Regulations under the Securities
Exchange Act of 1934.
2. One signed original and four conformed copies of this form and amendments thereto must be completed and filed with
the Securities and Exchange Commission, Washington, D.C. 20549, in accordance with Rule 0-3 of the General Rules and
Regulations under the Act. The information contained in or filed with the form will be made a matter of public
record in the Commission files.
3. A manually signed copy of the form and amendments thereto shall be filed with each national securities exchange on
which any class of securities of the registrant is registered.
4. Amendments to the notifications must also be filed on form 12b-25 but need not restate information that has been
correctly furnished. The form shall be clearly identified as an amended notification.
5. Electronic Filers. This form shall not be used by electronic filers unable to timely file a report solely due to
electronic difficulties. Filers unable to submit a report within the time period prescribed due to difficulties
in electronic filing should comply with either Rule 201 or Rule 202 of Regulation S-T (Section 232.201 or Section
232.202 of this chapter) or apply for an adjustment in filing date pursuant to Rule 13(b) of Regulation S-T
(Section 232.13(b) of this chapter.)
</TABLE>
